Hepato-Pancreato-Biliary Malignancies

Hepato-Pancreato-Biliary cancers are increasing in incidence, with pancreatic cancer now accounting for the third most cancer deaths in the United States.  Typically these malignancies, as a group, are managed by the same key providers comprising a multidisciplinary team.

 

This book is intended to provide a comprehensive review of the current knowledge in the field of hepato-pancreato-biliary malignancies, focusing on the practical and clinical care of patients.  We take the approach of combining the collective expertise of an interventional gastroenterologist and a hepato-pancreato-biliary surgeon to provide the readers with accurate, succinct, and pragmatic information needed to formulate the most appropriate treatment plan for their patients with the aim of the best possible outcome.  

 

Managing patients with these cancers continues to be challenging because of continued dismal survival rates. Each section in this text is written by experts in their respective field, summarizing the most state-of-the-art, contemporary diagnostic and therapeutic tools available in the field. We believe this book will prove to be an invaluable, comprehensive resource for all members of the multidisciplinary team caring for patients with hepato-pancreato-biliary malignancies.

Dr. Cataldo Doria is an internationally renowned surgeon who specializes in surgical treatments of the liver, pancreas, and bile duct. Dr. Doria spent a quarter of a century in academic medicine, at University of Pittsburg Medical Center in Pittsburgh first, and at Thomas Jefferson University Hospital in Philadelphia later.

Dr. Doria was a major contributor to the start-up of the European Medical Division of the University of Pittsburgh Medical Center, which resulted in a cultural and scientific cooperative agreement between the University of Pittsburgh and the University of Palermo - Italy. This partnership led to the development of the Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione,(IsMeTT), a health care delivery system that serves the entire Mediterranean Basin and specializes in solid organ transplantation and cancer care.  From 1999 to 2003, Dr Doria, was the clinical leader of IsMeTT. 

At Thomas Jefferson University Hospital in Philadelphia, PA, he served as the surgical director of the Sidney Kimmel Cancer Center – Jefferson Liver Tumor Center at Jefferson Medical College, and director of the Jefferson Transplant Institute.  During his 15 years tenure at Jefferson Dr. Doria resurrected, first hand, a program in agony and made it one of the best in the Country for volume, outcome, patient satisfaction, and innovative research.

Dr. Doria received his medical degree at University of Perugia School of Medicine in Italy, where he also completed his internship and residency. He completed a research fellowship and a clinical fellowship in multi-organ transplant surgery at the Pittsburgh Transplantation Institute, part of the University of Pittsburgh School of Medicine in Pittsburgh, PA. Dr. Doria is a PhD in biotechnology and transplant immunology; he is, also, one of the few Doctors worldwide that successfully completed a clinical fellowship in living donor liver transplantation atthe Organ Transplantation Center, part of Asan Medical Center in Seoul, South Korea.  Dr. Doria is a 2016 Temple Fox School of Business graduate.

Dr. Doria is currently the Medical Director of the Cancer Center at Capital Health in Pennington, NJ. During the first three years of his tenure at Capital Health, under Dr. Doria’s leadership, the net revenue of the cancer center increased in excess of 25% every year.

Dr. Doria has pioneered new techniques for conditions that were once considered untreatable. He has helped developing and introducing a number of innovative procedures to treat cancer patients that were not previously available, including bloodless liver surgery, ex-vivo liver resection with liver auto-transplantation and robotic-assisted hepato-pancreato-biliary surgery. He completed the first robotic assisted Whipple procedure in the State of New Jersey.

Dr. Jason N. Rogart
As an interventional gastroenterologist and therapeutic endoscopist, Dr. Rogart performs the latest and most advanced procedures for the testing and non-surgical treatment of pancreato-biliary disorders and malignancies. He is nationally recognized as an expert in the fields of endoscopic ultrasound (EUS), endoscopic retrograde cholangiopancreatography (ERCP), pseudocyst drainage, enteral stent placement, advanced endoscopic imaging, as well as numerous other procedures which help in the care of patients with gastrointestinal malignancies. 

 

Dr. Rogart received his medical degree from Brown Medical School and completed his internship and residency at Yale University in the Department of Internal Medicine at Yale-New Haven Hospital, where he was also Chief Resident. He completed his fellowship training in digestive diseases at Yale University/Yale-New Haven Hospital and subsequently was an Advanced Endoscopy fellow in the Division of Gastroenterology & Hepatology at Thomas Jefferson University Hospital in Philadelphia, PA. Dr. Rogart holds an academic appointment at Rutgers—Robert Wood Johnson Medical School. 

 

Dr. Rogart has published numerous original research articles and chapters in various national and international journals and resource textbooks. He has also been an invited speaker and faculty member at numerous locoregional and national conferences, including Digestive Diseases Week, the American Society for Gastrointestinal Endoscopy, the American College of Gastroenterology and the Society of Gastrointestinal Nurses and Associates. He is a reviewer for several national and international clinical publications.

 

In 2014, Dr. Rogart was awarded the honorable distinction of “Fellow” in the American Society of Gastrointestinal Endoscopy (FASGE) for his lifelong contributions to the field of GI endoscopy and his dedication to patient care, research, teaching, and service.